Socio-economic status, ethnicity and geographical variations in acceptance rates for renal replacement therapy in England and Wales: An ecological study

Journal of Epidemiology and Community Health

Volumn 64, Issue 6, 2010, Pages 535-541

  Udayaraj, Udaya P ^a   Ben Shlomo, Yoav ^b   Roderick, Paul ^c   Casula, Anna ^a   Ansell, David ^a   Tomson, Charles R V ^a   Caskey, Fergus J ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE CLASS; DATA ASSIMILATION; DIGESTIVE SYSTEM; ECOLOGICAL APPROACH; ETHNICITY; GENDER; GEOGRAPHICAL VARIATION; HEALTH SERVICES; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SOCIOECONOMIC STATUS;

ARTICLE; CHRONIC KIDNEY FAILURE; ETHNOLOGY; HUMAN; PATIENT ATTITUDE; POISSON DISTRIBUTION; PSYCHOLOGICAL ASPECT; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY; SOCIAL CLASS; SOCIOECONOMICS; UNITED KINGDOM;

ENGLAND; HUMANS; KIDNEY FAILURE, CHRONIC; PATIENT ACCEPTANCE OF HEALTH CARE; POISSON DISTRIBUTION; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY; SOCIAL CLASS; SOCIOECONOMIC FACTORS; WALES;

ENGLAND; UNITED KINGDOM; WALES;

EID: 77953801656     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2009.093518     Document Type: Article

References (49)

1. Foley R, Parfrey P, Sarnak M. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-19.
2. Gokal R, Figueras M, Olle A, et al. Outcomes In peritoneal dialysis and haemodialysis-a comparative assessment of survival and quality of life. Nephrol Dial Transplant 1999;14:24-30. (Pubitemid 29462211)
3. De Vecchi A, Dratwa M, Wiedemann M. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: costs and reimbursement/ funding of ESRD therapies. Nephrol Dial Transplant 1999;14:31-41. (Pubitemid 29462212)
4. Farrington K, Udayaraj U, Gilg J, et al. Ihe tenth annual report. Chapter 3: new adult patients starting renal replacement therapy in the UK in 2006. Bristol: UK Renal Registry, 2007.
5. Roderick P, Davies R, Jones C, et al. Simulation model of renal replacement therapy: predicting future demand in England. Nephrol Dial Transplant 2004;19:692-701. (Pubitemid 38263132)
6. Feest T, Rajamahesh J, Taylor H, et al. Ihe provision of renal replacement therapy for adults in the UK 1998. London: Department of Health, 2000.
7. Caskay FJ, Schobor-Halstonborg HJ, Roderick PJ, et al. Exploring the differences in epidemiology of treated LSRD between Germany and Lngland and Wales. Am J Kidney Dis 2006;47:445-454
8. Office of the National Statistics (London), http://www.statistics.gov.uk.
9. Townsend P, Philllmore P, Beattie A. Health and deprivation: inequality and the north. London: Croom Holm, 1988.
10. Cass A, Cunningham J, Hoy W. The relationship between the incidence of end-stage renal disease and markers of socioeconomic disadvantage. N S W Public Health Bull 2002;13:147-151
11. Volkova N, McClellan W, Klein M, et al. Neighborhood poverty and racial differences in LSRD incidence. J Am Soc Nephrol 2008:19:356 64.
12. Ward MM. Socioeconomic status and the incidence of ESRD. Am J Kidney Dis 2008;51:563-572
13. Young EW, Mauger LA, Jiang KH, et al. Socioeconomic status and end-stage renal disease in the United States. Kidney Int 1994;45:907-911 (Pubitemid 24094507)
14. Maheswaran R, Payne N, Meechan D, et al. Socioeconomic deprivation, travel distance, and renal replacement therapy in the trent region, United Kingdom 2000: An ecological study. J Epidemiol Community Health 2003;57:523-524
15. Roderick P, Clements S, Stone N, et al. What determines geographical variation in rates of acceptance onto renal replacement therapy in England? J Health Serv Res Policy 1999;4:139-146 (Pubitemid 29338763)
16. Morris K, Nissenson AR. Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 2008;19:1261-1270
17. Shoham DA, Vupputuri S, Kaufman JS, et al. Kidney disease and the cumulative burden of life course socioeconomic conditions: the atherosclerosis risk in communities (ARIC) study. Soc Sci Med 2008;67:1311-1320
18. Drey N, Roderick P, Mullee M, et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003;42:677-684 (Pubitemid 37187367)
19. Fored CM, Ejerblad E, Fryzek JP, et al. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. Nephrol Dial Transplant 2003;18:82-88 (Pubitemid 36104482)
20. Shoham DA, Vupputuri S, Kshirsagar AV. Chronic kidney disease and life course socioeconomic status: a review. Adv Chronic Kidney Dis 2005;12:56-63. (Pubitemid 40255604)
21. Marmot MG, Smith GD, Stansfold S, et al. Health inequalities among British civil servants: the Whitehall ii study. Lancet 1991;337:1387-1393
22. Krop JS, Coresh J, Chambless LE, et al. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the atherosclerosis risk in communities study. Arch Intern Med 1999;159:1777-1783 (Pubitemid 29379142)
23. Merkin SS, Coresh J, Roux AV, et al. Area socioeconomic status and progressive ckd: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 2005;46:203-213 (Pubitemid 41040348)
24. Metcalfe W, MacLeod AM, Bennett D, et al. Equity of renal replacement therapy utilization: a prospective population-based study. OJM 1999;92:637-642 (Pubitemid 29515869)
25. Khan IH, Cheng J, Catto GR, et al. Social deprivation indices of patients on renal replacement therapy (RRT) in Grampian. Scott Med J 1993;38:139-141 (Pubitemid 23323794)
26. Fischbacher CM, Steiner M, Bhopal R, et al. Variations in all cause and cardiovascular mortality by country of birth in Scotland, 1997-2003. Scott Med J 2007;52:5 10.
27. Hanlon P, Lawder RS, Buchanan D, et al. Why is mortality higher in Scotland than in Lngland and Wales? decreasing influence of socioeconomic deprivation between 1981 and 2001 supports the existence of a 'Scottish effect.' J Public Health (Oxf) 2005;27:199-204.
28. Marang-van de Mheen PJ, Davey Smith G, Hart CL, et al. Socioeconomic differentials in mortality among men within Great Britain: time trends and contributory causes. J Epidemiol Community Health 1998;52:214-218 (Pubitemid 28176815)
29. Klag MJ, Whelton PK, Randall BL, et al. Lnd-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997;277:1293-1298
30. Narva AS. Kidney disease in native americans. J Natl Med Assoc 2002;94:738-742
31. Xue JL, Lggers PW, Agodoa LY, et al. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol 2007;18:1299-1306
32. USRDS. 2006 annual data report: atlas of end-stae renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2006.
33. Lightstone L, Rees AJ, Iomson C, et al. High incidence of end-stage renal disease in Indo-Asians in the UK. QJM 1995;88:191-195
34. Roderick PJ, Raleigh VS, Hallam L, et al. The need and demand for renal replacement therapy in ethnic minorities in England. J Epidemiol Community Health 1996;50:334-339 (Pubitemid 26237091)
35. Department of health. Saving lives: our healthier nation. London: Hmso, 1999.
36. Bryson CL, Ross HJ, Boyko EJ, et al. Racial and ethnic variations in albuminuria in the us third national health and nutrition examination survey (NHANES iii) population: associations with diabetes and level of CKD. Am J Kidney Dis 2006;48:720-726
37. Tarver-Carr ME, Powe NR, Eberhardt MS, et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a populationbased study of potential explanatory factors. J Am Soc Nephrol 2002;13:2363-2370
38. Shoham DA, Vupputuri S, Diez Roux AV, et al. Kidney disease in life-course socioeconomic context: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 2007;49:217-226 (Pubitemid 46178404)
39. Hsu CY, Lin F, Vittinghoff E, et al. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 2003;14:2902-2907
40. Peralta CA, Ziv E, Katz R, et al. African ancestry, socioeconomic status, and kidney function in elderly African-Americans: a genetic admixture analysis. J Am Soc Nephrol 2006;17:3491-3496
41. McLean G, Guthrie B, Sutton M. Differences in the quality of primary medical care for CVD and diabetes across the NHS: Evidence from the quality and outcomes framework. BMC Health Serv Res 2007;7:74.
42. Anon. Chapter 3: health status, illnesses and other comorbid conditions. In: Dolman R, Kingdon A, Roberts C, eds. Welsh health survey. Cardiff: Statistics for Wales, 2007.
43. Anon. Volume 2: risk factors for cardiovascular disease. In: Sproston K, Primatesta P, eds. Health survey for England 2003. London: National Centre for Social Research and Department of Epidemiology and Public Health at the Royal Free and University College Medical School, 2004.
44. Ansell D, Feest T. The sixth annual report: chapter 3. National renal review 2002: smmary report on adult and paediatric renal services. Bristol: UK Renal Registry, 2003, pp 15-41.
45. The association of publich health observatories. CKD stage 3-5 prevalence estimates for local authority and primary care trust areas. http://www.Apho.Org.Uk, (accessed 2 Dec 2008).
46. Eames M, Ben-Shlomo Y, Marmot MG. Social deprivation and premature mortality: regional comparison across England. BMJ 1993;307:1097-1102
47. Allender S, Peto V, Scarborough P, et al. Coronary heart disease statistics. London: British Heart Foundation (http://www.Heartstats.Org), 2008.
48. Couchoud C, Guihenneuc-Jouyaux C, Stengel B. Do lcoal practices regarding timing of dialysis initiation impact on renal replacement therapy incidence at district level? Data from the French REIN Registry (Abstract). J Am Soc Nephrol 2008;19:768A.
49. Julious SA, Nicholl J, George S. Why do we continue to use standardized mortality ratios for small area comparisons? J Public Health Med 2001;23:40-46